GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Integragen (XPAR:ALINT) » Definitions » Notes Receivable

Integragen (XPAR:ALINT) Notes Receivable : €0.00 Mil (As of Jun. 2024)


View and export this data going back to 2010. Start your Free Trial

What is Integragen Notes Receivable?

Integragen's Notes Receivable for the quarter that ended in Jun. 2024 was €0.00 Mil.


Integragen Notes Receivable Historical Data

The historical data trend for Integragen's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Integragen Notes Receivable Chart

Integragen Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Notes Receivable
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Integragen Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Notes Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Integragen Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.


Integragen Notes Receivable Related Terms

Thank you for viewing the detailed overview of Integragen's Notes Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


Integragen Business Description

Traded in Other Exchanges
N/A
Address
Genopole Campus 1 - Genavenir, 85 rue Henri Desbrueres, Evry, FRA, 91000
Integragen is engaged in the development of genetic biomarkers. It offers genomic and bioinformatic services, including clinical research, basic and human genetic research, bioinformatics and bioanalysis, agrigenomics, and genomics news, as well as genomic research tools and solutions to microbiologic researchers.

Integragen Headlines

No Headlines